Pulmagen Therapeutics pulmagen.com


Public lists: Pharma Startups (4733)

Pulmagen develops novel and proprietary drugs for chronic respiratory diseases including COPD and asthma. These therapies aim to deliver both improved bronchodilator symptomatic relief and treat the underlying inflammatory disease process. Pulmagen intends to progress its programs through Phase II proof-of-concept clinical trials and identify strategic partners for later stage clinical development.

Pulmagen develops novel and proprietary drugs for chronic respiratory diseases including COPD and asthma. These therapies aim to deliver both improved bronchodilator symptomatic relief and treat the underlying inflammatory disease process. Pulmagen i...Show all

Company (Alive / Active)

Phone:

Fax:

The Coach House, Grenville Court
Britwell Road, Burnham
Slough, SL1 8DF
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pulmagen Therapeutics $0M Jun 6, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pulmagen Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
MVM Life Science PartnersVenture CapitalLondon, England, United KingdomOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhaled combination therapy Mar 14, 2013 Jul 21, 2015 Patent
Respiratory disease treatment Apr 07, 2014 Jul 14, 2015 Patent
Respiratory disease treatment Jun 29, 2012 Aug 26, 2014 Patent
Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases Feb 13, 2006 Apr 30, 2013 Patent
Inhaled combination therapy Aug 24, 2010 Apr 23, 2013 Patent
See all 7 patents